National Institute for Health and Clinical Excellence

Lord Foulkes of Cumnock Excerpts

Wednesday 14th December 2011 Lords Chamber

[Earl Howe]

My Lords, part of the objective of the growth strategy is to break down some of the barriers that undoubtedly exist to pharmaceutical companies conducting clinical trials in this country. There have been unwelcome delays in the system and we are putting in place several measures to get rid of them, which in turn should encourage pharmaceutical companies to view the UK as the platform of choice for clinical research.

[Lord Foulkes of Cumnock]

My Lords, has the Minister thought—